First-in-Human (FIH) Trial
**What it means:** This is the **very first time a drug is given to people** — never humans before, only animals (and cell cultures). It's essentially Phase 1a. The goals are: 1. **Safety** — does the...
Explainers
Plain-English explanations of MEF2C research terms, concepts, and scientific mechanisms.
MicroRNA Therapeutic Advantage (why MUSC chose RNA over gene therapy)
**What it means:** The MUSC team evaluated multiple approaches (gene therapy, micro-RNA therapeutics) and chose the RNA-based approach because it "offered several advantages." These likely include: - ...
Patient-Derived (in cell biology context)
**What it means:** "Patient-derived" means cells, tissues, or samples that were taken **directly from a patient** (usually via biopsy or blood draw) and used in research. This is different from cancer...
International Patent (WIPO/WO2026039331)
**What it means:** The WO2026039331 patent published through WIPO (World Intellectual Property Organization) covers the viral gene therapy approach for MEF2C. "WO" indicates a Patent Cooperation Treat...
Fc-gamma Receptor Signaling
**What it means:** Fc-gamma receptors are "antenna" proteins on microglia that detect antibodies attached to targets (like synaptic connections). When an antibody flags a synapse, the Fc-gamma recepto...
CARD11 (and why it matters)
**What it means:** CARD11 is a **scaffold protein** — it acts like a docking station that brings inflammatory signaling molecules together. When a microglial receptor detects a threat, CARD11 assemble...
Blood-Brain Barrier (BBB) Penetrance
The Blood-Brain Barrier (BBB) is like a **military checkpoint** between your bloodstream and your brain. It's made of tightly packed cells with no gaps — designed to keep toxins out. But it also keeps...
Inpart (Industry Partnering Platform)
**What it means:** Inpart is a **global scientific partnering platform** used by 90% of the world's top 50 pharmaceutical companies. Think of it as LinkedIn for drug development — it tracks which acad...
Longitudinal Data / Longitudinal Study
**What it means:** Longitudinal data is collected from the **same subjects repeatedly over time** — like taking photos of the same tree every year to watch it grow. This is different from a cross-sect...
Germline Mosaicism (rare inheritance mechanism)
**What it means:** Germline mosaicism is a rare phenomenon where a parent has a mutation in some of their reproductive cells (sperm or eggs) but NOT in their body cells. This means the parent tested "...
Oncology / Solid Tumor (in CDK2 inhibitor context)
**What it means:** Oncology is the branch of medicine that deals with cancer. "Solid tumors" are cancers that form actual lumps or masses (as opposed to blood cancers like leukemia). Breast, ovarian, ...
KRAS Pathway / MAPK/ERK Signaling Pathway
First: What Even Is a "Pathway"?Cells aren't just blobs of jelly. They're incredibly organized — like a giant office building where every department needs to know what to do, when to do it, and who's ...
Epic / Epigenetics (broader concept)
**What it means:** Epigenetics is the study of changes in gene **activity** that don't involve changes to the DNA sequence itself. Think of your DNA as a piano — the keys (genes) are always there. Epi...
Retrospective Study
**What it means:** A retrospective study looks **backward in time** at existing data — reviewing past patient records, genetic test results, and clinical outcomes to find patterns. It's less rigorous ...
De Novo Mutation
**What it means:** A de novo (Latin for "from new") mutation is a genetic change that occurs **for the first time** in a person — it wasn't inherited from either parent. The parents' DNA is normal; th...
CDK4/6 Inhibitor (related to MHS research)
**What it means:** CDK4 and CDK6 are proteins closely related to CDK2. They all work together to drive cell division. CDK4/6 inhibitors (like palbociclib, ribociclib, abemaciclib) are already FDA-appr...
NEDHSIL (Neurodevelopmental Disorder with Hypotonia, Stereotypic Hand Movements, and Impaired Language)
**What it means:** NEDHSIL is the **alternative name** for MEF2C-associated syndrome. It describes the core clinical features without naming the gene. You might see it in older papers or clinical note...
Natural History Study
**What it means:** A natural history study systematically tracks a disease **without giving any treatment**. It's like creating a detailed map of a territory before you try to change it — you need to ...